| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
49,181 |
46,119 |
$1.85M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17,665 |
17,628 |
$808K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,864 |
16,214 |
$599K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
13,755 |
13,674 |
$591K |
| 99050 |
|
5,716 |
5,489 |
$263K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
409 |
389 |
$15K |
| 81002 |
|
4,791 |
4,691 |
$14K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,258 |
2,136 |
$11K |
| 81025 |
|
2,915 |
2,868 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,216 |
1,182 |
$4K |
| 99000 |
|
683 |
676 |
$4K |
| A9150 |
Non-prescription drugs |
697 |
653 |
$3K |
| 81003 |
|
1,048 |
1,006 |
$3K |
| A4320 |
Irrigation tray with bulb or piston syringe, any purpose |
1,634 |
1,515 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
78 |
78 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
780 |
772 |
$2K |
| 93000 |
|
411 |
408 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
860 |
848 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
255 |
253 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
635 |
364 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
601 |
592 |
$1K |
| 73600 |
|
168 |
164 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
156 |
153 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
275 |
266 |
$825.50 |
| 99407 |
|
21 |
21 |
$395.75 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
25 |
25 |
$382.41 |
| 73620 |
|
84 |
81 |
$324.55 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
228 |
225 |
$322.25 |
| 73120 |
|
52 |
49 |
$279.03 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
176 |
175 |
$242.06 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
48 |
47 |
$240.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
196 |
185 |
$148.64 |
| 72100 |
|
12 |
12 |
$137.55 |
| 73100 |
|
16 |
16 |
$131.73 |
| 64450 |
|
13 |
13 |
$129.14 |
| 73140 |
|
12 |
12 |
$95.59 |
| A6448 |
Light compression bandage, elastic, knitted/woven, width less than three inches, per yard |
68 |
68 |
$80.00 |
| 69210 |
|
48 |
47 |
$80.00 |
| 99441 |
|
65 |
56 |
$20.52 |
| 82948 |
|
73 |
73 |
$16.26 |
| A6403 |
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing |
15 |
13 |
$1.36 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
23 |
23 |
$0.00 |
| A6252 |
Specialty absorptive dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
33 |
28 |
$0.00 |
| 73560 |
|
15 |
14 |
$0.00 |
| A6220 |
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
15 |
13 |
$0.00 |